AI
Tuesday, August 03, 2021 4:04:18 PM
Certainly hoping (praying) Locust Walk (or similar) is in charge of anything M&A related for IPIX.
Our lack of sufficient data related to trials-completed remains our largest obstacle to deal-making to date IMO.
If Sanofi can take Translate for $38 bucks a share as a Covid slayer; does that raise the bar to be the same for a potential for Briliacidin? I would think comparatively that IPIX has an equal if not better pipeline as an acquisition target.
From the distribution of Fierce Biotech today.
Recent IPIX News
Lingerie Fighting Championships Signs Broadcast Deal With Maybacks Global Entertainment • BOTY • Sep 26, 2024 9:00 AM
Maybacks Global Entertainment and Lingerie Fighting Championships Enter Into Broadcast And Revenue Sharing Agreement • AHRO • Sep 26, 2024 8:30 AM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
